Clinical Trials Browser

Completed × Interventional × Mast Cell Activation Disorders × Clear all

Mast Cell Activation Disorders, Carcinoma, Non-Small-Cell Lung, Glioma, Leukemia, Mast-Cell, Melanoma, Neoplasms, Germ Cell and Embryonal, Penile Neoplasms, Sarcoma, Mastocytosis, Systemic, Gastrointestinal Stromal Tumors, Renal Insufficiency

NCT04978740 2022-12-01

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Phase NA Completed

21 enrolled

Mast Cell Activation Syndrome, Mast Cell Activation Disorders, Urticaria Pigmentosa

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Phase 4 Completed

10 enrolled

Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Clinical Trials

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Imatinib in KIT-negative Systemic Mastocytosis